Covered recipient · General Payments record
DIALYN SOTO-BARRETO
Allopathic & Osteopathic Physicians Internal Medicine Geriatric Medicine
General Payments · PY2020–2023
$1,750.61
- Reported across 114 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.30 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $75.52 | 4 |
| Lilly USA, LLC | $63.04 | 4 |
| Amgen Inc. | $30.62 | 2 |
| Acerta Pharma LLC | $30.12 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $17.49 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019893473 | CMS |
| Amgen Inc. | $13.13 | 10/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020567711 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.70 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015377147 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.42 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011663817 | CMS |
| Lilly USA, LLC | $14.97 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031459511 | CMS |
| Lilly USA, LLC | $15.90 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031372549 | CMS |
| Lilly USA, LLC | $16.27 | 08/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031393123 | CMS |
| Lilly USA, LLC | $15.90 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031339243 | CMS |
| Novo Nordisk Inc | $23.71 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002294617 | CMS |
| Novo Nordisk Inc | $17.90 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002294591 | CMS |
| Novo Nordisk Inc | $13.47 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002294579 | CMS |
| Novo Nordisk Inc | $20.44 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002294605 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.